Health CanadaGeneral Alert

ANZEMET (dolasetron mesylate) – Withdrawal of 20 mg/mL Intravenous Injection Due to Potential Risk of Arrhythmias – For the Public

Name: ANZEMET (dolasetron mesylate) – Withdrawal of 20 mg/mL Intravenous Injection Due to Potential Risk of Arrhythmias – F...
Brand: Marketed health products
SKU: CANADA-24489
Availability: Discontinued
Rating: 1.0 (1 reviews)

Published: April 28, 2011Recall ID: 24489Category: generalCountry: Canada

Safety AlertHealth Canada Canada

Canada

ANZEMET (dolasetron mesylate) – Withdrawal of 20 mg/mL Intravenous Injection Due to Potential Risk of Arrhythmias – For the Public

Recalling Firm: Marketed health products

Product Description & Identification

ANZEMET (dolasetron mesylate) – Withdrawal of 20 mg/mL Intravenous Injection Due to Potential Risk of Arrhythmias – For the Public

Additional Source Details

Field	Value
N I D	24489
U R L	https://recalls-rappels.canada.ca/en/alert-recall/anzemet-dolasetron-mesylate-withdrawal-20-mgml-intravenous-injection-due-potential
Title	ANZEMET (dolasetron mesylate) – Withdrawal of 20 mg/mL Intravenous Injection Due to Potential Risk of Arrhythmias – For the Public
Archived	1
Category	Drugs
Last updated	2011-04-28
Organization	Marketed health products

Check Other Products In Your Household

Free Safety Tools

Safety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:

Barcode Scanner VIN Vehicle Check Pantry Safety Audit

Overview

Recalling FirmMarketed health products

Recall Hazard Severity

Caution (Class III)

Official Agency Alert

📢 Share Warning

Alert family and friends to keep them safe. Copy this quick alert message:

🚨 SAFETY ALERT: Marketed health products - ANZEMET (dolasetron mesylate) – Withdrawal of 20 mg/mL Intravenous Injection Due to Potential Risk of Arrhythmias – For the Public

Check if your household is affected:
https://therecallfile.com/recalls/anzemet-dolasetron-mesylate-withdrawal-of-20-mg-ml-intravenous-injecti/CANADA-24489

WhatsApp Facebook

Join Alertlist

Get instant email updates whenever critical safety recalls like this are published.

Featured on Product Hunt

Help support our public safety mission and check out our community launch.

Support The Recall File

Help keep official recall alerts free, accessible, and fast for everyone.

Spread the WordANZEMET (dolasetron mesylate) – Withdrawal of 20 mg/mL Intravenous Injection Due to Potential Risk of Arrhythmias – For the Public

ANZEMET (dolasetron mesylate) – Withdrawal of 20 mg/mL Intravenous Injection Due to Potential Risk of Arrhythmias – For the Public

ANZEMET (dolasetron mesylate) – Withdrawal of 20 mg/mL Intravenous Injection Due to Potential Risk of Arrhythmias – For the Public

Product Description & Identification

Additional Source Details

Check Other Products In Your Household

Overview

📢 Share Warning

Join Alertlist

Featured on Product Hunt

Support The Recall File

Install The Recall File App

Notification

ANZEMET (dolasetron mesylate) – Withdrawal of 20 mg/mL Intravenous Injection Due to Potential Risk of Arrhythmias – For the Public

ANZEMET (dolasetron mesylate) – Withdrawal of 20 mg/mL Intravenous Injection Due to Potential Risk of Arrhythmias – For the Public

Product Description & Identification

Additional Source Details

Check Other Products In Your Household

Overview

📢 Share Warning

Join Alertlist

Featured on Product Hunt

Support The Recall File

Related Recalls

Transport Canada Recall - 2018088 -

Transport Canada Recall - 2018088 -

Transport Canada Recall - 2018288 -

Transport Canada Recall - 2018288 -

Transport Canada Recall - 2018409 -

Transport Canada Recall - 2018409 -

Install The Recall File App

Notification